Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Correction: Mathew et al. Metabolic Signature of Warburg Effect in Cancer: An Effective and Obligatory Interplay between Nutrient Transporters and Catabolic/Anabolic Pathways to Promote Tumor Growth. ICancers/I 2024, I16/I, 504Cancers, 2024-05, Vol.16 (9) [Peer Reviewed Journal]COPYRIGHT 2024 MDPI AG ;ISSN: 2072-6694 ;EISSN: 2072-6694 ;DOI: 10.3390/cancers16091627Full text available |
|
2 |
Material Type: Article
|
The Importance of HHLA2 in Solid Tumors-A Review of the LiteratureCells (Basel, Switzerland), 2024-05, Vol.13 (10), p.794 [Peer Reviewed Journal]COPYRIGHT 2024 MDPI AG ;2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2073-4409 ;EISSN: 2073-4409 ;DOI: 10.3390/cells13100794 ;PMID: 38786018Full text available |
|
3 |
Material Type: Article
|
Correction to "Projected estimates of cancer in Canada in 2024"Canadian Medical Association journal (CMAJ), 2024-06, Vol.196 (17), p.E731-E731 [Peer Reviewed Journal]COPYRIGHT 2024 CMA Impact Inc. ;2024 CMA Impact Inc. or its licensors 2024 ;ISSN: 0820-3946 ;EISSN: 1488-2329 ;DOI: 10.1503/cmaj.240712Full text available |
|
4 |
Material Type: Article
|
MicroRNA-34 and gastrointestinal cancers: a player with big functionsCancer cell international, 2024-05, Vol.24 (1), p.163-163 [Peer Reviewed Journal]2024. The Author(s). ;2024. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1475-2867 ;EISSN: 1475-2867 ;DOI: 10.1186/s12935-024-03338-w ;PMID: 38725047Full text available |
|
5 |
Material Type: Article
|
Gynecological cancer survivors’ experiences and desire for follow-up after recent treatment: A phenomenological hermeneutic studyISSN: 0162-220X ;EISSN: 1538-9804 ;DOI: 10.1097/NCC.0000000000001252Digital Resources/Online E-Resources |
|
6 |
Material Type: Article
|
COVID-19 and Cancer Detection in RussiaCancers, 2024-05, Vol.16 (9), p.1673 [Peer Reviewed Journal]COPYRIGHT 2024 MDPI AG ;2024 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2072-6694 ;EISSN: 2072-6694 ;DOI: 10.3390/cancers16091673 ;PMID: 38730625Full text available |
|
7 |
Material Type: Article
|
Patients' satisfaction with cancer pain treatment at adult oncologic centers in Northern Ethiopia; a multi-center cross-sectional studyBMC cancer, 2024-05, Vol.24 (1), p.647-647 [Peer Reviewed Journal]2024. The Author(s). ;COPYRIGHT 2024 BioMed Central Ltd. ;The Author(s) 2024 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-024-12359-7 ;PMID: 38802773Full text available |
|
8 |
Material Type: Article
|
Molecular and Therapeutic Roles of Non-Coding RNAs in Oral Cancer-A ReviewMolecules (Basel, Switzerland), 2024-05, Vol.29 (10), p.2402 [Peer Reviewed Journal]COPYRIGHT 2024 MDPI AG ;2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1420-3049 ;EISSN: 1420-3049 ;DOI: 10.3390/molecules29102402 ;PMID: 38792263Full text available |
|
9 |
Material Type: Article
|
Adenovirus-mediated expression of MOAP-1, Bax and RASSF1A antagonizes chemo-drug resistance of human breast cancer cells expressing cancer stem cell markersBiomedicine & pharmacotherapy, 2024-07, Vol.176, p.116744-116744, Article 116744 [Peer Reviewed Journal]2024 The Authors ;Copyright © 2024 The Authors. Published by Elsevier Masson SAS.. All rights reserved. ;ISSN: 0753-3322 ;EISSN: 1950-6007 ;DOI: 10.1016/j.biopha.2024.116744 ;PMID: 38810399Full text available |
|
10 |
Material Type: Article
|
Oral cancer: estimate nas capitais do BrasilRevista de medicina (São Paulo, Brazil), 2024-03, Vol.103 (2)COPYRIGHT 2024 Universidade de Sao Paulo. Departamento Cientifico da Faculdade de Medicina ;ISSN: 1679-9836 ;EISSN: 1679-9836 ;DOI: 10.116Q6/issn.1679-9836.v1Q3i2e-224Q62Full text available |
|
11 |
Material Type: Article
|
Oral cancer: estimateRevista de medicina (São Paulo, Brazil), 2024-03, Vol.103 (2)COPYRIGHT 2024 Universidade de Sao Paulo. Departamento Cientifico da Faculdade de Medicina ;ISSN: 1679-9836 ;EISSN: 1679-9836Full text available |
|
12 |
Material Type: Article
|
Hyaluronic Acid Interacting Molecules Mediated Crosstalk between Cancer Cells and Microenvironment from Primary Tumour to Distant MetastasisCancers, 2024-05, Vol.16 (10), p.1907 [Peer Reviewed Journal]COPYRIGHT 2024 MDPI AG ;2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2072-6694 ;EISSN: 2072-6694 ;DOI: 10.3390/cancers16101907 ;PMID: 38791985Full text available |
|
13 |
Material Type: Article
|
Prognostic value of the advanced lung cancer inflammation index in patients with gastric cancer after radical gastrectomy: a propensity-score matching cohort study and meta-analysisBMC cancer, 2024-05, Vol.24 (1), p.583-583 [Peer Reviewed Journal]2024. The Author(s). ;COPYRIGHT 2024 BioMed Central Ltd. ;2024. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2024 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-024-12349-9 ;PMID: 38741082Full text available |
|
14 |
Material Type: Article
|
Factors influencing presentation delay among cancer patients: a cross-sectional study in MalaysiaBMC public health, 2024-05, Vol.24 (1), p.1260-1260 [Peer Reviewed Journal]2024. The Author(s). ;COPYRIGHT 2024 BioMed Central Ltd. ;2024. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2024 ;ISSN: 1471-2458 ;EISSN: 1471-2458 ;DOI: 10.1186/s12889-024-18643-2 ;PMID: 38720253Full text available |
|
15 |
Material Type: Article
|
Tumor-Derived Antigenic Peptides as Potential Cancer VaccinesInternational journal of molecular sciences, 2024-05, Vol.25 (9), p.4934 [Peer Reviewed Journal]COPYRIGHT 2024 MDPI AG ;2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1422-0067 ;ISSN: 1661-6596 ;EISSN: 1422-0067 ;DOI: 10.3390/ijms25094934 ;PMID: 38732150Full text available |
|
16 |
Material Type: Article
|
Prognostic Value of B7H4 Expression in Patients with Solid Cancers: A Systematic Review and Meta-AnalysisInternational journal of molecular sciences, 2024-05, Vol.25 (9), p.5045 [Peer Reviewed Journal]COPYRIGHT 2024 MDPI AG ;2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1422-0067 ;ISSN: 1661-6596 ;EISSN: 1422-0067 ;DOI: 10.3390/ijms25095045 ;PMID: 38732263Full text available |
|
17 |
Material Type: Article
|
Correction: Childhood cancer survival in the highly vulnerable population of South Texas: A cohort studyPloS one, 2024-05, Vol.19 (5), p.e0303725-e0303725 [Peer Reviewed Journal]Copyright: © 2024 Wu et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. ;COPYRIGHT 2024 Public Library of Science ;2024 Wu et al 2024 Wu et al ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0303725 ;PMID: 38722978Full text available |
|
18 |
Material Type: Article
|
Comprehensive Pan-Cancer Analysis of Connexin 43 as a Potential Biomarker and Therapeutic Target in Human Kidney Renal Clear Cell Carcinoma (KIRC)Medicina (Kaunas, Lithuania), 2024-05, Vol.60 (5), p.780 [Peer Reviewed Journal]COPYRIGHT 2024 MDPI AG ;2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1648-9144 ;ISSN: 1010-660X ;EISSN: 1648-9144 ;DOI: 10.3390/medicina60050780 ;PMID: 38792963Full text available |
|
19 |
Material Type: Article
|
PSMA-Targeted Therapy: Advancements in Detection and Treatment Modalities with Dr. Scott T. TagawaCancers, 2024-05, Vol.16 (10), p.1833 [Peer Reviewed Journal]COPYRIGHT 2024 MDPI AG ;2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2072-6694 ;EISSN: 2072-6694 ;DOI: 10.3390/cancers16101833 ;PMID: 38791912Full text available |
|
20 |
Material Type: Article
|
Schlafens: Emerging Therapeutic TargetsCancers, 2024-05, Vol.16 (10), p.1805 [Peer Reviewed Journal]COPYRIGHT 2024 MDPI AG ;2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2072-6694 ;EISSN: 2072-6694 ;DOI: 10.3390/cancers16101805 ;PMID: 38791884Full text available |